Trial intelligence / Profile preview

Curcumin gel 5% vs triamcinolone acetonide 0.1% for recurrent aphthous stomatitis

IRCT201412242950N3Phase 3Completed

Sponsor
Research Vice Chancellorship of Guilan University of Medical Sciences
Start
Mar 2014
Modality
Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Small Molecules
Countries
1
01

Overview

Phase 3 trial of curcumin and triamcinolone acetonide in aphthosis (RAS) (2 arms), sponsored by Research Vice Chancellorship of Guilan University of Medical Sciences. Started Mar 2014; status: completed.

02

Drugs

curcumintriamcinolone acetonide
03

Conditions

aphthosis (RAS)

Beyond the preview

Go deeper on IRCT201412242950N3.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on IRCT201412242950N3.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call